Lesson plan
TMU4142
TMU4142 is a potent and selective serotonin 5-HT 1A receptor biased agonist. It is a preferential near-full agonist of the G oA pathway with weak agonism of the G i3 pathway and little or no β-arrestin2 recruitment. Presynaptic serotonin 5-HT 1A autoreceptors predominantly signal via the G i3 pathway in the dorsal raphe nucleus (DRN) and are associated with feedback inhibition that may hamper therapeutic effects, whereas postsynaptic serotonin 5-HT 1A heteroreceptors couple mainly to G o pathways in hippocampal and cortical areas and are thought to mediate antidepressant-like effects. As such, TMU4142 is a selective postsynaptic serotonin 5-HT 1A receptor agonist with the potential for greater antidepressant activity than other serotonin 5-HT 1A receptor agonists, such as 8-OH-DPAT, buspirone, gepirone, F-15599 (NLX-101), and vilazodone, among others. On the other hand, the G z pathway is thought to be involved in anxiolytic-like effects. Analogously to TMU4142, pindolol is a moderate-efficacy partial agonist of the G o pathways but a very weak partial agonist or antagonist of G i pathways. TMU4142 produces rapid antidepressant-like effects in rodents without modifying serotonin levels or neuronal firing rates in the DRN.…
Article summary
TMU4142 is a potent and selective serotonin 5-HT 1A receptor biased agonist. It is a preferential near-full agonist of the G oA pathway with weak agonism of the G i3 pathway and little or no β-arrestin2 recruitment. Presynaptic serotonin 5-HT 1A autoreceptors predominantly signal via the G i3 pathway in the dorsal raphe nucleus (DRN) and are associated with feedback inhibition that may hamper therapeutic effects, whereas postsynaptic serotonin 5-HT 1A heteroreceptors couple mainly to G o pathways in hippocampal and cortical areas and are thought to mediate antidepressant-like effects. As such, TMU4142 is a selective postsynaptic serotonin 5-HT 1A receptor agonist with the potential for greater antidepressant activity than other serotonin 5-HT 1A receptor agonists, such as 8-OH-DPAT, buspirone, gepirone, F-15599 (NLX-101), and vilazodone, among others. On the other hand, the G z pathway is thought to be involved in anxiolytic-like effects. Analogously to TMU4142, pindolol is a moderate-efficacy partial agonist of the G o pathways but a very weak partial agonist or antagonist of G i pathways. TMU4142 produces rapid antidepressant-like effects in rodents without modifying serotonin levels or neuronal firing rates in the DRN.…
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.